Cargando…
Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies
Autores principales: | Finsterer, Josef, Scorza, Fulvio A., Scorza, Carla A., Fiorini, Ana C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117663/ https://www.ncbi.nlm.nih.gov/pubmed/34023795 http://dx.doi.org/10.1016/j.jneuroim.2021.577609 |
Ejemplares similares
-
SARS-COV-2-Associated Guillain-Barre Syndrome Requires Appropriate Exclusion of Possible Differentials
por: Finsterer, Josef, et al.
Publicado: (2021) -
Is Guillain Barre syndrome truly caused by SARS-CoV-2?
por: Finsterer, Josef, et al.
Publicado: (2021) -
Guillain-Barre syndrome related to SARS-CoV-2 vaccinations
por: Finsterer, Josef, et al.
Publicado: (2022) -
Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
por: Finsterer, Josef, et al.
Publicado: (2021) -
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations
por: Finsterer, Josef, et al.
Publicado: (2022)